Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
Philip T. LoVerde,
Sevan N. Alwan,
Alexander B. Taylor,
Jayce Rhodes,
Frédéric D. Chevalier,
Timothy Jc Anderson,
Stanton F. McHardy
Affiliations
Philip T. LoVerde
Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA; Pathology and Laboratory Medicine, The University of Texas Health Science Center, San Antonio, TX, USA; Corresponding author. Departments of Biochemistry and Structural Biology, USA.
Sevan N. Alwan
Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
Alexander B. Taylor
Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
Jayce Rhodes
Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA
Frédéric D. Chevalier
Program in Host-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, TX, USA
Timothy Jc Anderson
Program in Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX, USA
Stanton F. McHardy
Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA
